Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-winn_army_community_hospital_pharmacy_stays_online_during_power_outage_1

British consumers have increasingly turned to community pharmacies during COVID-19

September 25, 2020
Medical Communications

British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study. Research conducted by …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 25, 2020
Medical Communications

The top 10 news stories this week focus on coronavirus vaccine trials, as around one in seven patients who have …

News

Novartis’ Zolgensma hits regulatory hurdle after FDA asks to review another study

September 24, 2020
Research and Development FDA

The FDA has requested an additional study in older children being treated with Novartis’ Zolgensma in the review process for …

News
credit_-_carl_recine__reuters

COVID-19 track and trace app launched in England and Wales after months of delays

September 24, 2020
Medical Communications, Sales and Marketing UK, VOCID-19, app, test and trace

The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays …

News
fda_21_4

FDA grants Emergency Use Authorization for first antibody point-of-care COVID-19 test

September 24, 2020
Research and Development

The FDA has issued an Emergency Use Authorization (EUA) for the first antibody (serology) point-of-care test for coronavirus.  This is …

News
vitaminsupplementpills

‘Smart drugs’ may contain unapproved pharmaceuticals, according to a new study

September 24, 2020
Sales and Marketing FDA, regulation, smart drugs

Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new …

News
49449461223_6e279556d2_b

Gilead agrees to pay $97 million to settle Medicare kickbacks case

September 24, 2020
Business Services Gilead, Medicare, drugs, kickbacks

Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity …

News
1

Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial

September 23, 2020
Research and Development AstraZeneca, COVID-19, Vaccine

The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …

News
credit_-_reuters

Fujifilm’s Avigan reduces recovery time in non-severe COVID-19 patients

September 23, 2020
Research and Development, Sales and Marketing

Fujifilm has announced promising new Phase 3 findings demonstrating that its antiviral therapy Avigan (favipravir) had a statistically significant impact …

News
fda_21

FDA set to announce stricter criteria for COVID-19 vaccines to receive Emergency Use Authorization

September 23, 2020
Research and Development

The FDA is set to release new guidelines that would raise safety and efficacy requirements required for a COVID-19 vaccine …

News
flu_shot_advertising

Contracting flu and COVID-19 simultaneously increases the risk of death, new study shows

September 23, 2020
Research and Development coronavirus vaccine, flu vaccine, vaccines

Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 23, 2020
Research and Development COVID-19, coronavirus

The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial …

News
shutterstock_2

AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal

September 22, 2020
Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma

AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …

News
study_participant_receives_niaid-gsk_candidate_ebola_vaccine

Clinical trials for Russia’s Sputnik-V vaccine in India could start in the coming weeks

September 22, 2020
Manufacturing and Production Russia Vaccine, vaccines

Clinical trials testing Russia’s Sputnik-V coronavirus vaccine in India could begin in the next few weeks, according to Indian pharma …

News
800px-centers_for_disease_control_and_prevention_-_main_entrance

CDC says its updated guidance stating coronavirus spreads through the air was posted in “error”

September 22, 2020
Manufacturing and Production CDC, COVID-19

The US Centers for Disease Control and Prevention (CDC) has removed its guidance that said coronavirus was transmitted through the …

News
merckincweb

Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer

September 22, 2020
Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma

MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …

News
Photo by Psiĥedelisto

Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus

September 22, 2020
Manufacturing and Production OxyContin, Purdue, Purdue Pharma

Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to pay CEO and President Craig …

News
shutterstock_38078521

New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020

September 21, 2020
Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda

New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …

News
800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced ovarian cancer

September 21, 2020
Sales and Marketing AstraZeneca

AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment …

News
800px-temazepam_10mg_tablets-1

Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency

September 21, 2020
Sales and Marketing thyroid, thyroid drugs

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026